ArticleOncoTargets and therapy2017

Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma.

Antonio Miguel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.